Pathologic response rates between gemcitabine-cisplatin (GC) and methotrexate, vinblastine, doxorubicin hydrochloride, and cisplatin (MVAC) neoadjuvant chemotherapy in muscle-invasive urothelial cell carcinoma of the bladder.
Jonathan Lawrence Wright
No relevant relationships to disclose
Franklin Lee
No relevant relationships to disclose
William Proctor Harris
No relevant relationships to disclose
Heather H. Cheng
No relevant relationships to disclose
Song Zhao
No relevant relationships to disclose
Thomas Champion
No relevant relationships to disclose
John L. Gore
No relevant relationships to disclose
James Dean
No relevant relationships to disclose
James Dean
No relevant relationships to disclose
Michael P Porter
No relevant relationships to disclose
Evan Y. Yu
No relevant relationships to disclose